ARCHIVED: NOT AVAILABLE FOR CREDIT
Urothelial Carcinoma of the Urinary Bladder

 

The presentation will discuss the current classification and staging of bladder cancer and important prognostic features that should be reported by pathologists. Specific diagnostic problems will also be discussed such as the separation of high grade urothelial carcinoma from prostate carcinoma, and spindle cell tumors of the urinary bladder.

Originally presented on January, 2014, in Salt Lake City, Utah.

Lecture Presenter

John C. Cheville, MD

John C. Cheville, MD

Professor of Pathology
Mayo Clinic, Rochester, MN

Dr. Cheville is a professor of pathology at the Mayo Clinic in Rochester, Minnesota. His research interests are genitourinary pathology, gastrointestinal pathology, and lymph node pathology.

Objectives

After this presentation, participants will be able to:

  • Understand the important prognostic features of urothelial carcinoma in radical cystectomy specimens.
  • Appreciate the current classification and recently described variants of urothelial carcinoma and challenges in diagnosis.
  • Understand the important staging issues in urothelial carcinoma including an evaluation of depth of invasion.

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories